Chemoinformaics analysis of 3,6-Dihydro-2H-thiopyran
| Molecular Weight | 100.186 | nRot | 0 |
| Heavy Atom Molecular Weight | 92.122 | nRig | 23 |
| Exact Molecular Weight | 100.035 | nRing | 1 |
| Solubility: LogS | -1.754 | nHRing | 1 |
| Solubility: LogP | 1.118 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 14 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 16.5843 |
| nHD | 0 | BPOL | 10.4857 |
| QED | 0.738 |
| Synth | 5.751 |
| Natural Product Likeliness | 1.918 |
| NR-PPAR-gamma | 0.619 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.981 |
| HIA | 0.062 |
| CACO-2 | -5.023 |
| MDCK | 0.0000109 |
| BBB | 0.878 |
| PPB | 0.184856 |
| VDSS | 5.303 |
| FU | 0.737424 |
| CYP1A2-inh | 0.024 |
| CYP1A2-sub | 0.279 |
| CYP2c19-inh | 0.021 |
| CYP2c19-sub | 0.781 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.195 |
| CYP2d6-inh | 0.055 |
| CYP2d6-sub | 0.654 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.452 |
| CL | 8.44 |
| T12 | 0.412 |
| hERG | 0.651 |
| Ames | 0.288 |
| ROA | 0.343 |
| SkinSen | 0.779 |
| Carcinogencity | 0.124 |
| EI | 0.005 |
| Respiratory | 0.517 |
| NR-Aromatase | 0.898 |
| Antiviral | No |
| Prediction | 0.956861 |